Journal
JOURNAL OF AFFECTIVE DISORDERS
Volume 234, Issue -, Pages 148-155Publisher
ELSEVIER
DOI: 10.1016/j.jad.2018.02.005
Keywords
Polygenic risk score; Bipolar disorder; Depression; Genetic; Phenotypes
Categories
Funding
- Mental Health Research UK
- Wellcome Trust GW4 Clinical Academic Training Fellowship
- NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust
- University of Bristol
- MRC [UKDRI-3003, MR/L023784/2, MR/L023784/1] Funding Source: UKRI
Ask authors/readers for more resources
Background: Identifying the phenotypic manifestations of increased genetic liability for depression (MDD) and bipolar disorder (BD) can enhance understanding of their aetiology. The polygenic risk score (PRS) derived using data from genome-wide-association-studies can be used to explore how genetic risk is manifest in different samples. Aims: In this systematic review, we review studies that examine associations between the MDD and BD polygenic risk scores and phenotypic outcomes. Methods: Following PRISMA guidelines, we searched EMBASE, Medline and PsycINFO (from August 2009 - 14th March 2016) and references of included studies. Study inclusion was based on predetermined criteria and data were extracted independently and in duplicate. Results: Twenty-five studies were included. Overall, both polygenic risk scores were associated with other psychiatric disorders (not the discovery sample disorder) such as depression, schizophrenia and bipolar disorder, greater symptom severity of depression, membership of a creative profession and greater educational attainment. Both depression and bipolar polygenic risk scores explained small amounts of variance in most phenotypes (< 2%). Limitations: Many studies did not report standardised effect sizes. This prevented us from conducting a meta-analysis. Conclusions: Polygenic risk scores for BD and MDD are associated with a range of phenotypes and outcomes. However, they only explain a small amount of the variation in these phenotypes. Larger discovery and adequately powered target samples are required to increase power of the PRS approach. This could elucidate how genetic risk for bipolar disorder and depression is manifest and contribute meaningfully to stratified medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available